Head lice are tiny wingless insects that do not fly or jump, their primary means of movement is crawling. The main way lice are spread is head to head contact. Lice are human parasites that feed on the blood of the infested person.

The Global Main Head Lice Infestation Drug Manufacturers are Bayer, Omega Pharma, Thornton and Ross, Prestige Brands and other manufacturers. Bayer is one of the largest manufacturers in the global Head Lice Infestation Drug market with 11.35% market share in 2015, followed by Omega Pharma with 7.98% market share.

The Head Lice Infestation Drug sales regions are mainly North America and Europe. North America is the largest region to consumption Head Lice Infestation Drug, whose consumption occupied about 31.40% in 2015, followed by Europe with 29.01% consumption share.

After a long investigation and research, we think people are very concerned about the Head Lice Infestation Drug content in the daily commodities. We recommend that some manufacturers would add Head Lice Infestation Drug to satisfy the market demanding for all household members and other close to head lice contacts should be checked.

According to this study, over the next five years the Head Lice Infestation Drug market will register a 4.3% CAGR in terms of revenue, the global market size will reach US$ 440 million by 2024, from US$ 340 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Head Lice Infestation Drug business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Head Lice Infestation Drug market by product type, application, key manufacturers and key regions and countries.

This study considers the Head Lice Infestation Drug value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.

Lotion

Creams

Shampoo

Other

Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.

Children

Adult

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Spain

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

Bayer

Omega Pharma

Thornton and Ross

Prestige Brands

Perrigo

Actavis

Reckitt Benckier

Tyratech

Shionogi

TecLabs

Arborpharma

Major Pharmaceuticals

Logic Products

Tianren

ParaPRO

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

To study and analyze the global Head Lice Infestation Drug consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.

To understand the structure of Head Lice Infestation Drug market by identifying its various subsegments.

Focuses on the key global Head Lice Infestation Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Head Lice Infestation Drug with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the consumption of Head Lice Infestation Drug submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

2019-2024 Global Head Lice Infestation Drug Consumption Market Report

1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Economic Indicators

1.6 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Head Lice Infestation Drug Consumption 2014-2024

2.1.2 Head Lice Infestation Drug Consumption CAGR by Region

2.2 Head Lice Infestation Drug Segment by Type

2.2.1 Lotion

2.2.2 Creams

2.2.3 Shampoo

2.2.4 Other

2.3 Head Lice Infestation Drug Consumption by Type

2.3.1 Global Head Lice Infestation Drug Consumption Market Share by Type (2014-2019)

2.3.2 Global Head Lice Infestation Drug Revenue and Market Share by Type (2014-2019)

2.3.3 Global Head Lice Infestation Drug Sale Price by Type (2014-2019)

2.4 Head Lice Infestation Drug Segment by Application

2.4.1 Children

2.4.2 Adult

2.5 Head Lice Infestation Drug Consumption by Application

2.5.1 Global Head Lice Infestation Drug Consumption Market Share by Application (2014-2019)

2.5.2 Global Head Lice Infestation Drug Value and Market Share by Application (2014-2019)

2.5.3 Global Head Lice Infestation Drug Sale Price by Application (2014-2019)

3 Global Head Lice Infestation Drug by Players

3.1 Global Head Lice Infestation Drug Sales Market Share by Players

3.1.1 Global Head Lice Infestation Drug Sales by Players (2017-2019)

3.1.2 Global Head Lice Infestation Drug Sales Market Share by Players (2017-2019)

3.2 Global Head Lice Infestation Drug Revenue Market Share by Players

3.2.1 Global Head Lice Infestation Drug Revenue by Players (2017-2019)

3.2.2 Global Head Lice Infestation Drug Revenue Market Share by Players (2017-2019)

3.3 Global Head Lice Infestation Drug Sale Price by Players

3.4 Global Head Lice Infestation Drug Manufacturing Base Distribution, Sales Area, Product Types by Players

3.4.1 Global Head Lice Infestation Drug Manufacturing Base Distribution and Sales Area by Players

3.4.2 Players Head Lice Infestation Drug Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Head Lice Infestation Drug by Regions

4.1 Head Lice Infestation Drug by Regions

4.1.1 Global Head Lice Infestation Drug Consumption by Regions

4.1.2 Global Head Lice Infestation Drug Value by Regions

4.2 Americas Head Lice Infestation Drug Consumption Growth

4.3 APAC Head Lice Infestation Drug Consumption Growth

4.4 Europe Head Lice Infestation Drug Consumption Growth

4.5 Middle East & Africa Head Lice Infestation Drug Consumption Growth

5 Americas

5.1 Americas Head Lice Infestation Drug Consumption by Countries

5.1.1 Americas Head Lice Infestation Drug Consumption by Countries (2014-2019)

5.1.2 Americas Head Lice Infestation Drug Value by Countries (2014-2019)

5.2 Americas Head Lice Infestation Drug Consumption by Type

5.3 Americas Head Lice Infestation Drug Consumption by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Head Lice Infestation Drug Consumption by Countries

6.1.1 APAC Head Lice Infestation Drug Consumption by Countries (2014-2019)

6.1.2 APAC Head Lice Infestation Drug Value by Countries (2014-2019)

6.2 APAC Head Lice Infestation Drug Consumption by Type

6.3 APAC Head Lice Infestation Drug Consumption by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Countries

7 Europe

7.1 Europe Head Lice Infestation Drug by Countries

7.1.1 Europe Head Lice Infestation Drug Consumption by Countries (2014-2019)

7.1.2 Europe Head Lice Infestation Drug Value by Countries (2014-2019)

7.2 Europe Head Lice Infestation Drug Consumption by Type

7.3 Europe Head Lice Infestation Drug Consumption by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Spain

7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Head Lice Infestation Drug by Countries

8.1.1 Middle East & Africa Head Lice Infestation Drug Consumption by Countries (2014-2019)

8.1.2 Middle East & Africa Head Lice Infestation Drug Value by Countries (2014-2019)

8.2 Middle East & Africa Head Lice Infestation Drug Consumption by Type

8.3 Middle East & Africa Head Lice Infestation Drug Consumption by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Head Lice Infestation Drug Distributors

10.3 Head Lice Infestation Drug Customer

11 Global Head Lice Infestation Drug Market Forecast

11.1 Global Head Lice Infestation Drug Consumption Forecast (2019-2024)

11.2 Global Head Lice Infestation Drug Forecast by Regions

11.2.1 Global Head Lice Infestation Drug Forecast by Regions (2019-2024)

11.2.2 Global Head Lice Infestation Drug Value Forecast by Regions (2019-2024)

11.2.3 Americas Consumption Forecast

11.2.4 APAC Consumption Forecast

11.2.5 Europe Consumption Forecast

11.2.6 Middle East & Africa Consumption Forecast

11.3 Americas Forecast by Countries

11.3.1 United States Market Forecast

11.3.2 Canada Market Forecast

11.3.3 Mexico Market Forecast

11.3.4 Brazil Market Forecast

11.4 APAC Forecast by Countries

11.4.1 China Market Forecast

11.4.2 Japan Market Forecast

11.4.3 Korea Market Forecast

11.4.4 Southeast Asia Market Forecast

11.4.5 India Market Forecast

11.4.6 Australia Market Forecast

11.5 Europe Forecast by Countries

11.5.1 Germany Market Forecast

11.5.2 France Market Forecast

11.5.3 UK Market Forecast

11.5.4 Italy Market Forecast

11.5.5 Russia Market Forecast

11.5.6 Spain Market Forecast

11.6 Middle East & Africa Forecast by Countries

11.6.1 Egypt Market Forecast

11.6.2 South Africa Market Forecast

11.6.3 Israel Market Forecast

11.6.4 Turkey Market Forecast

11.6.5 GCC Countries Market Forecast

11.7 Global Head Lice Infestation Drug Forecast by Type

11.8 Global Head Lice Infestation Drug Forecast by Application

12 Key Players Analysis

12.1 Bayer

12.1.1 Company Details

12.1.2 Head Lice Infestation Drug Product Offered

12.1.3 Bayer Head Lice Infestation Drug Sales, Revenue, Price and Gross Margin (2017-2019)

12.1.4 Main Business Overview

12.1.5 Bayer News

12.2 Omega Pharma

12.2.1 Company Details

12.2.2 Head Lice Infestation Drug Product Offered

12.2.3 Omega Pharma Head Lice Infestation Drug Sales, Revenue, Price and Gross Margin (2017-2019)

12.2.4 Main Business Overview

12.2.5 Omega Pharma News

12.3 Thornton and Ross

12.3.1 Company Details

12.3.2 Head Lice Infestation Drug Product Offered

12.3.3 Thornton and Ross Head Lice Infestation Drug Sales, Revenue, Price and Gross Margin (2017-2019)

12.3.4 Main Business Overview

12.3.5 Thornton and Ross News

12.4 Prestige Brands

12.4.1 Company Details

12.4.2 Head Lice Infestation Drug Product Offered

12.4.3 Prestige Brands Head Lice Infestation Drug Sales, Revenue, Price and Gross Margin (2017-2019)

12.4.4 Main Business Overview

12.4.5 Prestige Brands News

12.5 Perrigo

12.5.1 Company Details

12.5.2 Head Lice Infestation Drug Product Offered

12.5.3 Perrigo Head Lice Infestation Drug Sales, Revenue, Price and Gross Margin (2017-2019)

12.5.4 Main Business Overview

12.5.5 Perrigo News

12.6 Actavis

12.6.1 Company Details

12.6.2 Head Lice Infestation Drug Product Offered

12.6.3 Actavis Head Lice Infestation Drug Sales, Revenue, Price and Gross Margin (2017-2019)

12.6.4 Main Business Overview

12.6.5 Actavis News

12.7 Reckitt Benckier

12.7.1 Company Details

12.7.2 Head Lice Infestation Drug Product Offered

12.7.3 Reckitt Benckier Head Lice Infestation Drug Sales, Revenue, Price and Gross Margin (2017-2019)

12.7.4 Main Business Overview

12.7.5 Reckitt Benckier News

12.8 Tyratech

12.8.1 Company Details

12.8.2 Head Lice Infestation Drug Product Offered

12.8.3 Tyratech Head Lice Infestation Drug Sales, Revenue, Price and Gross Margin (2017-2019)

12.8.4 Main Business Overview

12.8.5 Tyratech News

12.9 Shionogi

12.9.1 Company Details

12.9.2 Head Lice Infestation Drug Product Offered

12.9.3 Shionogi Head Lice Infestation Drug Sales, Revenue, Price and Gross Margin (2017-2019)

12.9.4 Main Business Overview

12.9.5 Shionogi News

12.10 TecLabs

12.10.1 Company Details

12.10.2 Head Lice Infestation Drug Product Offered

12.10.3 TecLabs Head Lice Infestation Drug Sales, Revenue, Price and Gross Margin (2017-2019)

12.10.4 Main Business Overview

12.10.5 TecLabs News

12.11 Arborpharma

12.12 Major Pharmaceuticals

12.13 Logic Products

12.14 Tianren

12.15 ParaPRO

13 Research Findings and Conclusion

List of Tables and Figures

Figure Picture of Head Lice Infestation Drug

Table Product Specifications of Head Lice Infestation Drug

Figure Head Lice Infestation Drug Report Years Considere